BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20120404)

  • 1. Metabolic and physico-chemical urolithiasis parameters in the first morning urine.
    Serić V; Dutour-Sikirić M; Mihaljević I; Tucak-Zorić S; Bilić-Curcić I; Babić-Ivancić V
    Coll Antropol; 2009 Dec; 33 Suppl 2():85-92. PubMed ID: 20120404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic evaluation of urolithiasis patients from eastern Croatia.
    Babić-Ivancić V; Avdagić SC; Serić V; Kontrec J; Tucak A; Füredi-Milhofer H; Marković M
    Coll Antropol; 2004 Dec; 28(2):655-66. PubMed ID: 15666597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four hour and spot urine metabolic evaluations: correlations versus agreements.
    Hong YH; Dublin N; Razack AH; Mohd MA; Husain R
    Urology; 2010 Jun; 75(6):1294-8. PubMed ID: 19914693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary citrate excretion in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Majewski M; Borzecka H; Wawrzyszuk M; Zajaczkowska M
    Przegl Lek; 2006; 63 Suppl 3():134-6. PubMed ID: 16898511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
    Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
    Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A; Allie-Hamdulay S; Jackson G
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R; Czkwianianc E; Niedworok M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty four hours urine and serum biochemical parameters in patients with urolithiasis.
    Jawalekar S; Surve VT; Bhutey AK
    Nepal Med Coll J; 2010 Mar; 12(1):5-7. PubMed ID: 20677601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of biochemistry and diet in patients with enterocystoplasty who do and do not form stones.
    Hamid R; Robertson WG; Woodhouse CR
    BJU Int; 2008 Jun; 101(11):1427-32. PubMed ID: 18284409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.